Demographic variable
Description
Loss of smell n (%) No loss of smell n (%)
P value
Odds ratio (95% CI) Loss of taste n (%) No loss of taste n (%)
P value
Odds ratio (95% CI)
Sex
Male
92/217 (42.4%)
125/217 (57.6%)
<0.001
0.479 (0321 - 0.717)
89/217 (41%) 128/217 (59%)
0.002
0.532 (0.356-0.793)
Female
109/180 (60.6%) 71/180 (39.4%) 102/180 (56.7%) 78/180 (43.3%)
Nationality
Bahraini
146/264 (55.3%) 118/264 (44.7%)
0.001
N/A
139/264 (52.7%) 125/264 (47.3%)
0.002
N/A
GCC
4/5 (80%) 1/5 (20%) 5/5 (100%) 0/5 (0%)
Non GCC Arab
9/11 (81.8%) 2/11 (18.2%) 7/11 (63.6%) 4/11 (36.4%)
East Asia
6/13 (35.3%) 7/13 (53.8) 5/13 (38.5%) 8/13 (61.5%)
South Asia
36/102 (35.3%) 66/102 (64.7%) 35/102 (34.3%) 67/102 (65.7%)
Other
0/2 (0%) 2/2 (100%) 0/2 (0%) 2/2 (100%)
Marital status
Single
42/77 (54.5%) 35/77 (45.5%)
0.908
39/77 (50.6%) 38/77 (49.4%)
0.970
Married
154/309 (49.8%) 155/309 (50.2%) 147/309 (47.6%) 162/309 (52.4%)
Divorced
4/8 (50%) 4/8 (50%) 4/8 (50%) 4/8 (50%)
Widowed
1/2 (50%) 1/2 (50%) 1/2 (50%) 1/2 (50%)
Smoking status
Smoker
41/ 76 (53.9%) 35/76 (46.1%)
0.553
0.859 (1.42- 0.520,
41/76 (53.9%)
35/76 (46.1%)
0.298
0.766 (0.464 - 1.27)
Non smoker
158/315 (50.2%) 157/315 (49.8%)
149/315 (47.3%)
166/315 (52.7%)
Vaccination status
Pfizer
19/201 (9.5%)
22/196(5.5%)
0.647
NA
20/397 (5%)
21/397 (5.3%)
0.160
Sinopharm
65/118 (55.1%) 53/118 (44.9%)
65/118 (55.1%)
53/118 (44.9%)
Sputnik 19/40 (47.5%) 21/40 (52.5%) 17/40 (42.5%) 23/40 (57.5%)
COVISHILD
4/9 (44.4%) 5/9 (55.6%)
5/9 (55.5%)
4/9 (44.4%)
No vaccine
89/174 (51.1%) 85/174 (48.9%)
81/174 (46.6%)
93/174 (53.4%)
No record
5/15 (33.3%) 10/15 (66.7%)
3/15 (20%)
12/15 (80%)
Medical history
Sinusitis/ allergy
12/28 (42.9%) 16/28 (57.1%)
0.590
0.800 (0.355- 1.80)
12/28 (42.9%)
16/28 (57.1%)
0.921
0.960 (0.426 - 2.16)
Asthma / COPD
9/14 (64.3%) 4/14 (35.7%)
0.173
2.25 (0.681 - 7.43)
8/14 (57.1%)
5/14 (35.7%)
0.173
1.76 (0.565 - 5.47)